Keyphrases
Preeclampsia
100%
Angiotensin
100%
Angiotensin II (Ang II)
54%
Healthy Controls
36%
Nitric Oxide
27%
Endothelium-dependent Dilation
27%
Arginine
18%
Methyl Ester
18%
Control Site
18%
Vasodilator
18%
Constriction
18%
Endothelium-dependent Vasodilation
18%
Co-infusion
18%
Inducible Nitric Oxide Synthase
9%
Acetylcholine
9%
Vasoreactivity
9%
Therapeutic Target
9%
Remission
9%
Therapeutic Potential
9%
Clinical Symptoms
9%
Microvascular Function
9%
Microvasculature
9%
Nitric Oxide Synthase Inhibitors
9%
Druggable Targets
9%
Cutaneous Microcirculation
9%
Postpartum Women
9%
Endogenous Inhibitor
9%
Vascular Endothelial Dysfunction
9%
History of Preeclampsia
9%
Preeclamptic
9%
Medicine and Dentistry
Pre-Eclampsia
100%
Endothelial Function
100%
Angiotensin
100%
Angiotensin II
54%
Nitric Oxide
27%
Ligation
18%
Arginine Methyl Ester
18%
Vasoconstrictor
18%
Glyceryl Trinitrate
18%
Infusion
9%
Endothelial Dysfunction
9%
Vasodilatation
9%
Microcirculation
9%
Microvessel
9%
Acetylcholine
9%
Nitric Oxide Synthase
9%
Nitric Oxide Synthase Inhibitor
9%
Neuroscience
Angiotensin
100%
Angiotensin II
54%
Nitric Oxide
27%
Arginine Methyl Ester
18%
Nitric Oxide Synthase
18%
Vasoconstrictors
18%
Vasodilation
9%
Vasodilators
9%
Microvessel
9%
Acetylcholine
9%
Biochemistry, Genetics and Molecular Biology
Nitric Oxide
17%
Microcirculation
5%
Vasodilatation
5%